Alkermes Plc (ALKS US)

Analysis

Health Care • Ireland

Alkermes PLC researches pharmaceuticals. The Company develops treatments for central nervous system disorders such as addiction, schizophrenia and depression; and diabetes.

Refresh

Focused

No publications yet

There aren’t any sponsored reports right now

Back to "All"

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00